Related Experiment Video
Updated: Mar 12, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Molecular Pathophysiology of Congenital Long QT Syndrome
M S Bohnen1, G Peng1, S H Robey1
1Department of Pharmacology, Columbia University Medical Center, New York, New York; and The New York Stem Cell Foundation Research Institute, New York, New York.
Abstract:
Ion channels represent the molecular entities that give rise to the cardiac action potential, the fundamental cellular electrical event in the heart. The concerted function of these channels leads to normal cyclical excitation and resultant contraction of cardiac muscle. Research into cardiac ion channel regulation and mutations that underlie disease pathogenesis has greatly enhanced our knowledge of the causes and clinical management of cardiac arrhythmia. Here we review the molecular determinants, pathogenesis, and pharmacology of congenital Long QT Syndrome. We examine mechanisms of dysfunction associated with three critical cardiac currents that comprise the majority of congenital Long QT Syndrome cases: 1) IKs, the slow delayed rectifier current; 2) IKr, the rapid delayed rectifier current; and 3) INa, the voltage-dependent sodium current. Less common subtypes of congenital Long QT Syndrome affect other cardiac ionic currents that contribute to the dynamic nature of cardiac electrophysiology. Through the study of mutations that cause congenital Long QT Syndrome, the scientific community has advanced understanding of ion channel structure-function relationships, physiology, and pharmacological response to clinically employed and experimental pharmacological agents. Our understanding of congenital Long QT Syndrome continues to evolve rapidly and with great benefits: genotype-driven clinical management of the disease has improved patient care as precision medicine becomes even more a reality.
Insights
Congenital Long QT Syndrome (LQTS) involves cardiac ion channel dysfunction, particularly IKs, IKr, and INa currents. Studying LQTS mutations advances understanding of ion channel function and guides precision medicine for arrhythmias.
Area of Science:
- Cardiac Electrophysiology
- Molecular Cardiology
- Ion Channel Physiology
Background:
- Cardiac action potentials are generated by ion channels, crucial for heart muscle contraction.
- Mutations in cardiac ion channels can lead to arrhythmias, like congenital Long QT Syndrome (LQTS).
- Understanding LQTS pathogenesis is key to managing cardiac electrical disorders.
Purpose of the Study:
- To review the molecular determinants, pathogenesis, and pharmacology of congenital Long QT Syndrome.
- To examine dysfunction mechanisms in critical cardiac currents (IKs, IKr, INa) associated with LQTS.
- To highlight advancements in ion channel research driven by LQTS studies.
Main Methods:
- Review of existing literature on congenital Long QT Syndrome.
- Analysis of molecular mechanisms underlying dysfunction of key cardiac ion currents.
- Examination of structure-function relationships and pharmacological responses related to LQTS mutations.
Main Results:
- Congenital LQTS is primarily linked to dysfunction in slow delayed rectifier (IKs), rapid delayed rectifier (IKr), and voltage-dependent sodium (INa) currents.
- Mutations causing LQTS provide insights into ion channel structure, function, and physiology.
- Research has improved understanding of pharmacological agents for treating LQTS.
Conclusions:
- Study of LQTS mutations significantly enhances knowledge of ion channel behavior and cardiac electrophysiology.
- Genotype-driven management is improving patient care, making precision medicine a reality for LQTS.
- Continued research into LQTS offers benefits for understanding and treating cardiac arrhythmias.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pharmacodynamic Models: Linear Concentration–Effect Model
ATP Synthase: Mechanism
Inborn Errors of Metabolism
Incomplete Dominance

